Use Analytics to Navigate Markets, Align Value, and Accelerate Uptake.
Old-school strategies relying on siloed pricing models, outdated claims data, or anecdotal provider insights can’t keep up with:
of launch failures link to poor market access planning
of payers require real-world evidence for reimbursement
Access strategy today must be powered by continuous intelligence — not just policy knowledge.
Use ML models to anticipate denial rates, prior-authorization frictions, and listing delays
Identify and map advocacy strength, sentiment shifts, and alignment with payer narratives
Country-by-country scoring of pricing headroom, competitive positioning, and adoption likelihood
Connect real-world patient outcomes to cost-offsets and adherence impact with statistical clarity
Visual dashboards showing out-of-pocket burdens, co-pay assistance uptake, and access gaps
Clustered insights into national, regional, and institutional payers — from budget drivers to value expectations
Data-backed modeling of ROI, QALY gains, and risk-sharing agreements
Real-time tracking of HTA decisions, formulary updates, and reimbursement trends across global markets
Real-time tracking of HTA decisions, formulary updates, and reimbursement trends across global markets
Data-backed modeling of ROI, QALY gains, and risk-sharing agreements
Clustered insights into national, regional, and institutional payers — from budget drivers to value expectations
Visual dashboards showing out-of-pocket burdens, co-pay assistance uptake, and access gaps
Connect real-world patient outcomes to cost-offsets and adherence impact with statistical clarity
Country-by-country scoring of pricing headroom, competitive positioning, and adoption likelihood
Identify and map advocacy strength, sentiment shifts, and alignment with payer narratives
Use ML models to anticipate denial rates, prior-authorization frictions, and listing delays
In the access economy, value isn’t declared — it’s proven, modeled, and defended with data.
We blend data engineering, life sciences economics, and strategic consulting to deliver platforms and dashboards that inform, predict, and adapt access strategy at every stage.
Real-time monitoring of pricing corridors, payer positions, and HTA submissions by country or molecule class
Dynamic simulations of ICER, budget impact, and cost-benefit tradeoffs based on input assumptions and outcome scenarios
Pull real-world adherence, hospitalization, and quality-of-life data directly into economic argumentation models
NLP-powered analysis of payer interviews, advisory boards, and tender documentation to uncover resistance triggers
Rank-launch geographies based on regulatory timelines, access probability, competition maturity, and margin scenarios
Equip market access, medical affairs, and pricing teams with unified access to the same strategic intelligence
INT. doesn’t just build analytics — we embed evidence into every pricing, access, and launch decision.
Discover how your data can be restructured to power smarter, faster, and stronger market entry decisions.
You’ll get:
We go beyond maintaining operations—we empower businesses with data, insights, and best practices to stay ahead in an ever-evolving digital landscape.